课题基金 / 基金详情

Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in the Progression of Diabetic Nephropathy: Friend or foe?

Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in the Progression of Diabetic Nephropathy: Friend or foe?
核因子红细胞 2 相关因子 2 (Nrf2) 在糖尿病肾病进展中：是友还是敌？
批准号：
321283
负责人：
Chan John S
金额：
$47.82万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-03-01 至 2020-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=321283&lang=en
关键词：
Angiotensinogen Diabetes Diabetic Nephropathy Heterogeneous Nuclear Ribonucleoproteins Hypertension Knockout Mice Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Oxidative Stress Renin-Angiotensin System Transgenic Mice

项目摘要

项目成果

Chan John S的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Diabetes and persistent hypertension are two major risk factors for cardiovascular disease, stroke, heart attack and kidney failure. Intensive insulin therapy and chronic treatment with inhibitors of a hormonal system called renin-angiotensin system (RAS)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
Reactive Oxygen Species, Bcl-2-Modifying Factor and Tubular Atrophy in Diabetic Kidneys
海外基金